SUMMARY The priming principle was investigated in the rat phrenic nerve-diaphragm preparation stimulated continuously at 0.2 Hz. Tubocurarine was added to the organ bath as either a single (non-primed) or a divided (primed) dose. Priming consisted of 15% or 20% of the final dose, with priming intervals of 5 or 10 min. Priming decreased significantly the time to 80% block and was associated with mild neuromuscular block. A simple model adequately predicted the time to 50% and 80% block, using the same diffusion constant for both primed and non-primed conditions. The onset of neuromuscular block, with and without priming, depended mostly upon the distribution of the drug to its site(s) of action.

MATERIALS AND METHODS
Male Sprague-Dawley rats were killed humanely and the left phrenic nerve-hemidiaphragm dissected and removed. The tissue was bathed in physiological saline solution (a modified Krebs containing (mmol litre-'): NaCl 118; NaHCO :1 25; KC1 3.3; KH.PO, 1.1; CaCL 2.5; MgCl., 0.9; glucose 11.1; choline chloride 0.01; pH = 7.4 at 37 °C) and aerated with carbon dioxide in oxygen. The left hemidiaphragm was cut into a strip approximately 5 mm wide, with the phrenic nerve inserting at its middle. Surgical silk suture (4-0) was tied around a small fragment of ribs and fixed to a post in the middle of a glass organ bath maintained at 37 °C containing 30 ml of physiological saline. The central tendon was ligated and connected to an isometric tension transducer (Grass FT-03). The phrenic nerve was ligated and drawn through a circular bipolar stimulating electrode which was suspended in the saline. The length of the preparation was adjusted to yield maximum tension to supramaximal stimulation of the phrenic nerve at 0.2 Hz (0.2-ms square wave).
After equilibration, tubocurarine was added in volumes of less than 200 ul. The drug treatment was divided into two periods. In the first period, a "priming dose" of 15 or 20% of the total dose, or no drug, was added. After a priming interval of 5 or 10 min, the remainder of the dose or the total dose was given. The final drug concentrations were approximately two or three times the ED 95 .
Neuromuscular block was measured as the percent decrease in twitch tension from that immediately preceding the first period. The times to 50 and 80 % block of contractile tension (T i0 and r 80 ) were measured from the beginning of the second period. One experiment was performed on each phrenic nerve-diaphragm preparation.
We examined the hypothesis that the onset of neuromuscular block, with and without priming, could be described by an application of Fick's law of diffusion. Rats were assigned randomly to one of six groups of eight animals. One group received tubocurarine in various concentrations, in order to determine a steady state concentrationresponse relationship. Both T b0 and T so were measured in the other five experimental groups to which tubocurarine was given. Three groups with a final concentration of 4.5 umol litre" 1 were primed as follows: 20 % for 5 min, 15 % for 10 min and 20 % for 10 min. Two groups were not primed (final concentration tubocurarine 4.5 and 3.0 umol litre" 1 ). A typical recording of a primed preparation is shown in figure 1 .
To test the diffusion hypothesis, we used the
', where C = concentration of drug at its site of action; A = drug concentration in bath; C o = initial concentration at site of action; k = diffusion constant; and t = time. C was related to percent block by a dose-response relationship determined from stable degrees of block from single (non-primed) doses, k was calculated from non-primed (C o = 0) preparations given tubocurarine 3.0 umol litre" 1 and used in making predictions for the other groups. When predicting the onset of block following the administration of the second dose, C o was estimated by calculating C at the end of the priming interval, using the Fick equation above.
Results are reported as mean (SEM). Comparisons were made by one-way analyses of variance followed by Dunnett's test, with P < 0.05 regarded as significant.
RESULTS
The percent block produced by tubocurarine was determined for eight concentrations at steady state. The relationship between block and concentration was: % block = (130 log C) + 73 (r = 0.94). The calculated ED 95 was approximately 1.5 umol litre" 1 . In all preparations, tubocurarine both 3 and 4.5 umol litre" 1 produced 100% neuromuscular block. The diffusion constant (k) for tubocurarine was derived by solving the Fick equation for k using both the mean T i(l and the mean T so for tubocurarine 3.0 umol litre" 1 and averaging the two values. This mean k {k = 0.00086) was used to predict T M and r 80 for all tubocurarine-treated groups.
Priming significantly decreased onset time, as measured by T b0 and r 80 (tables I, II). The Fick model adequately predicted the onset of neuromuscular block. Table I shows that four of five predictions of T b0 were within 10% and 1 SEM of observed means. The least accurate prediction was within 20 % and the 95 % confidence interval 1 was given at the start of period I and the balance given after a 10-min priming interval. The recording periods are separated on the trace for clarity. 504 (66) 356 (28) 266 ( of the observed mean. Similarly, all the predicted 7^,, values were within 10% and 1 SEM of observed means (table II) . There was a small degree of neuromuscular block at the end of the priming period ( fig. 2 ).
DISCUSSION
Our data showed that priming accelerated the rate of onset of neuromuscular block in an in vitro rat preparation. Significant decreases in onset time were associated with a small degree of neuromuscular block produced by the priming dose, as has been demonstrated also in preliminary studies using vecuronium [17] . A simple model, based on Fick's law of diffusion, adequately described the onset of neuromuscular block (tables I, II) both with and without priming. Thus priming did not appear to change the effect of tubocurarine at its site(s) of action: These results are consistent with the hypothesis that the priming principle is a pharmacokinetic principle, and depends mostly on the distribution of a blocking drug to the neuromuscular junction. Although our results cannot exclude the possibility that prejunctional receptors are involved in acceleration of neuro-muscular block produced by priming [3, 5, 6] , the priming principle is explained reasonably well without recourse to such considerations.
The model of the priming principle has predictive value ( fig. 3) . It indicates that an effective way of increasing the rate of neuromuscular block is by increasing drug concentration. It predicts further that the rate constant for the onset of neuromuscular block is not affected by priming. Thus the time to peak drug concentration (and thus the maximum block) is not changed by priming. Rather, the time to a given degree of neuromuscular block is decreased by priming. This may not be obvious if muscle force is measured, as transmission as determined from endplate potentials may be reduced beyond that which results in 100 °0 block of induced twitch [18] .
The model also indicates ( fig. 3 ) how the effectiveness of priming is related to C o , the concentration of drug achieved at the neuromuscular junction at the end of the priming interval. It appears that small changes in C ( , do not greatly decrease the time to 100°,, block of induced twitch. Thus changes in priming dose or interval which do not have a significant effect on C n are not likely to change substantially the time to 100°( ) block.
The clinical situation differs from our in vitro system in several respects. The drug is distributed to more compartments in vivo and is eliminated. The neuromuscular blocking drug may interact with a variety of other drugs used in the clinical setting and there are species differences in sensitivities to neuromuscular blocking drugs [19] . Thus the in vitro model may not completely equate with the clinical setting. However, the model accords with several clinical studies and permits generalizations. Small increases in priming doses did not substantially increase the effectiveness of priming in clinical studies [6, 15] . The model indicates that the decreased onset time of small increases in priming dose or interval would be small and would be obscured by the variable responsiveness of nervemuscle systems to non-depolarizing blocking drugs in clinical settings [20] . Donati and colleagues [21] came to a similar conclusion using a model of human neuromuscular block. reduces weakness, and thus respiratory impairment, while retaining an appreciably accelerated onset of complete block. However, techniques that potentiate the block when the induction dose is administered (for example synergistic combinations of non-depolarizing blocking drugs [21] ) would be expected to improve the priming principle.
